Terms: = Thyroid cancer AND CRTC1, Q6UUV9, 23373, ENSG00000105662, KIAA0616, TORC1, MECT1, WAMTP1, FLJ14027
5 results:
1. crtc1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland.
Von Holstein SL; Fehr A; Heegaard S; Therkildsen MH; Stenman G
Oncol Rep; 2012 May; 27(5):1413-6. PubMed ID: 22323114
[TBL] [Abstract] [Full Text] [Related]
2. Synergistic action of a RAF inhibitor and a dual PI3K/mTOR inhibitor in thyroid cancer.
Jin N; Jiang T; Rosen DM; Nelkin BD; Ball DW
Clin Cancer Res; 2011 Oct; 17(20):6482-9. PubMed ID: 21831957
[TBL] [Abstract] [Full Text] [Related]
3. crtc1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: evidence for a common genetic association.
Bell D; Luna MA; Weber RS; Kaye FJ; El-Naggar AK
Genes Chromosomes Cancer; 2008 Apr; 47(4):309-14. PubMed ID: 18181164
[TBL] [Abstract] [Full Text] [Related]
4. crtc1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.
Tirado Y; Williams MD; Hanna EY; Kaye FJ; Batsakis JG; El-Naggar AK
Genes Chromosomes Cancer; 2007 Jul; 46(7):708-15. PubMed ID: 17437281
[TBL] [Abstract] [Full Text] [Related]
5. Recurrent fusion oncogenes in carcinomas.
Teixeira MR
Crit Rev Oncog; 2006 Dec; 12(3-4):257-71. PubMed ID: 17425505
[TBL] [Abstract] [Full Text] [Related]